Viewing Study NCT02713256


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-01-05 @ 1:59 AM
Study NCT ID: NCT02713256
Status: COMPLETED
Last Update Posted: 2021-01-05
First Post: 2016-03-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graves' Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Graves' disease View
None Hyperthyroidism View
None CFZ533 View
None TSH View